Correlation Between Global Health and Bio Gene

Can any of the company-specific risk be diversified away by investing in both Global Health and Bio Gene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Global Health and Bio Gene into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Global Health and Bio Gene Technology, you can compare the effects of market volatilities on Global Health and Bio Gene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Global Health with a short position of Bio Gene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Global Health and Bio Gene.

Diversification Opportunities for Global Health and Bio Gene

0.56

Correlation Coefficient

Global Health  Bio Gene

Very weak diversification

The 3 months correlation between Global and Bio is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding Global Health and Bio Gene Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bio Gene Technology and Global Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Global Health are associated (or correlated) with Bio Gene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bio Gene Technology has no effect on the direction of Global Health i.e., Global Health and Bio Gene go up and down completely randomly.

Pair Corralation between Global Health and Bio Gene

Assuming the 90 days trading horizon Global Health is expected to generate 0.61 times more return on investment than Bio Gene. However, Global Health is 1.65 times less risky than Bio Gene. It trades about 0.14 of its potential returns per unit of risk. Bio Gene Technology is currently generating about 0.02 per unit of risk. If you would invest  13.00  in Global Health on September 17, 2024 and sell it today you would earn a total of  1.00  from holding Global Health or generate 7.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Global Health  vs.  Bio Gene Technology

Global Health

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Global Health are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable technical indicators, Global Health is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Bio Gene Technology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bio Gene Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Bio Gene is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Global Health and Bio Gene

The main advantage of trading using opposite Global Health and Bio Gene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Global Health position performs unexpectedly, Bio Gene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bio Gene will offset losses from the drop in Bio Gene's long position.

The idea behind Global Health and Bio Gene Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.